Does Medicare Cover Spravato? Part B Rules and Costs

The short answer

Yes. Medicare covers Spravato under Part B for treatment-resistant depression when you have failed at least two oral antidepressants and continue one during treatment. Original Medicare pays 80 percent after the Part B deductible; a Medigap supplement covers most of the rest. Medicare Advantage plans cover it with prior authorization and their own copays.

Medicare covers Spravato. The coverage is real and has been in place since shortly after the FDA approved the drug in 2019. What trips people up is the mechanics: Spravato is not a prescription you fill at a pharmacy, so it does not go through Part D. It is a drug administered in a clinic under supervision, which puts it under Part B, the outpatient medical benefit, alongside things like chemotherapy infusions and injections given in a doctor's office.

Why Part B and not Part D

Spravato cannot be dispensed for home use. The FDA approved it under a Risk Evaluation and Mitigation Strategy (REMS) that requires the drug to be given in a certified clinic with two hours of monitoring afterward. Medicare treats drugs that must be administered by or under the supervision of a physician as Part B drugs. That classification has three consequences.

Your Part D plan, and its formulary and tiers, do not apply.
You pay Part B cost sharing: the annual deductible, then 20 percent coinsurance on the Medicare-approved amount.
A Medigap supplement, which covers Part B coinsurance, applies to Spravato.

Both the drug and the two-hour monitoring service are billed under Part B.

Medicare's criteria

Medicare covers Spravato for its FDA-approved indications, which are treatment-resistant depression in adults and major depressive disorder with acute suicidal ideation or behavior, in both cases alongside an oral antidepressant. In practice, the clinic must document:

A diagnosis of major depressive disorder, with severity measured by a rating scale.
Inadequate response to at least two different oral antidepressants, at adequate dose and duration, in the current episode.
That you are taking an oral antidepressant during Spravato treatment.
Treatment at a REMS-certified clinic with the required monitoring.
No contraindications: aneurysmal vascular disease, arteriovenous malformation, history of intracerebral hemorrhage, or known hypersensitivity.

Original Medicare does not operate a formal prior authorization process for Spravato; the clinic must document eligibility in the record and bill accordingly. Medicare Advantage plans do require prior authorization, submitted by the clinic before the first session.

What you pay

Coverage	Drug and monitoring cost to you	Notes
Original Medicare, no supplement	Part B deductible, then 20 percent of the approved amount per session	Roughly $150 to $250 per session at Medicare rates; adds up across induction
Original Medicare plus Medigap Plan G	Part B deductible only	Lowest total cost
Original Medicare plus Medigap Plan N	Deductible plus small office copays	Up to $20 per visit
Medicare Advantage	Plan copay or coinsurance per session, up to the plan's out-of-pocket maximum	Prior authorization required; must use a network clinic
Medicare plus Medicaid (dual eligible)	Often $0	Medicaid covers the Part B cost sharing

The Medicare-approved amount for Spravato is set by its average sales price plus a fixed percentage, and it is lower than commercial rates. Twenty percent of that, for an 84 mg dose plus monitoring, lands in the range of $150 to $250 per session. Over an eight-session induction month, that is $1,200 to $2,000 for someone on Original Medicare without a supplement. With Plan G, it is the deductible and nothing more.

Why the copay card does not apply

Janssen's Spravato copay savings program is a lifeline for commercially insured patients, but federal anti-kickback rules bar manufacturers from offering copay assistance to Medicare, Medicaid, TRICARE or VA beneficiaries. If a clinic tells you a Medicare patient can use the copay card, that is a mistake. The options for Medicare patients are a Medigap supplement, a Medicare Advantage plan with a reasonable copay, or, for patients with limited income, Medicare Savings Programs and Extra Help that reduce cost sharing.

Medicare Advantage specifics

Medicare Advantage plans must cover Spravato because Original Medicare does, but they manage it more actively.

Prior authorization is standard. The clinic submits your history and the plan responds, usually within two weeks.
Network rules apply. The clinic must be in your plan's network, or you need an out-of-network authorization.
Cost sharing varies widely. Some plans charge a flat copay per session; others charge 20 percent coinsurance like Original Medicare. All have an annual out-of-pocket maximum, which caps your total.
Some plans require a documented TMS trial or additional medication trials beyond the FDA label. These extra requirements can be appealed.

Finding a clinic that takes Medicare for Spravato

Not every REMS-certified Spravato clinic accepts Medicare, and some that do accept Original Medicare are out of network for specific Medicare Advantage plans. Janssen's treatment center locator lists certified sites but does not reliably show insurance participation, so call before assuming. Ask three questions: do you accept my specific plan, do you have a psychiatrist on site during sessions, and will you give me a written cost estimate before I start. Medicare.gov's Care Compare tool lists psychiatrists who accept Medicare assignment but does not indicate which offer Spravato.

Older adults and Spravato

The Spravato trials included a dedicated study in patients aged 65 and older. Response rates were somewhat lower than in younger adults, and the FDA label notes this, but a meaningful share of older patients did respond, and the safety profile was similar. Blood pressure deserves closer attention in older patients, because Spravato causes a temporary rise that peaks about 40 minutes after dosing, and many older adults already have hypertension. Clinics check blood pressure before dosing and will hold treatment if it is too high.

Older adults also take more medications. Spravato has few drug interactions, but combining it with benzodiazepines or other sedatives increases sedation during the session, and the clinic will review your medication list.

Getting started on Medicare

The process at Stedfast Psychiatry is the same for Medicare patients as for anyone else, with one difference: there is no copay card to enroll in.

A psychiatric evaluation at any of our 13 offices or by telehealth, documenting your diagnosis, past treatments and current antidepressant.
Benefits verification, and prior authorization if you have Medicare Advantage.
A written cost estimate based on your specific coverage.
Treatment at one of our REMS-certified Spravato offices: Boynton Beach, Palm Beach Gardens or Royal Palm Beach.

Patients from our Treasure Coast, Space Coast, North Florida and South Carolina offices are referred to the nearest Spravato site; the induction phase requires twice-weekly visits for four weeks, so distance is a practical consideration we will discuss honestly.

Bottom line

Medicare covers Spravato under Part B for treatment-resistant depression. Your cost depends on whether you have a supplement: close to zero with Medigap Plan G, roughly $150 to $250 per session with Original Medicare alone, and a plan-specific copay with Medicare Advantage. The manufacturer copay card does not apply. The clinic documents eligibility, handles any authorization and tells you what you will owe before you start.

Frequently asked questions

Is Spravato covered under Medicare Part B or Part D?

Part B. Spravato must be given in a certified clinic with monitoring, which makes it a physician-administered drug under Medicare rules. Your Part D plan and its formulary do not apply, and Part B cost sharing (deductible plus 20 percent) does.

What does Spravato cost on Medicare?

With Original Medicare alone, about $150 to $250 per session after the Part B deductible. With a Medigap Plan G supplement, only the deductible. Medicare Advantage plans set their own copays, often $0 to $75 per session, capped by the plan's out-of-pocket maximum.

Can Medicare patients use the Spravato copay card?

No. Federal rules prohibit manufacturer copay assistance for Medicare and Medicaid beneficiaries. Medigap, Medicare Advantage plans and Medicare Savings Programs are the ways to limit cost.

Does Medicare require TMS before Spravato?

Original Medicare does not. Some Medicare Advantage plans add a TMS trial or extra medication trials to their criteria; these requirements go beyond the FDA label and can be appealed with supporting documentation.

Does Medicare Cover Spravato?